Table: Towa Pharmaceutical -2022/23 group results

TOWA PHARMACEUTICAL

15/05/2023 07:00

May 15 (Reuters)- 
          Towa Pharmaceutical Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to       NEXT   
                Mar 31, 2023    Mar 31, 2022   Mar 31, 2024     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales            208.86          165.62         216.30        104.60   
                                 (+6.9 pct)                              
  Operating          5.51           19.21          11.80          5.80   
                                 (-3.6 pct)                              
  Recurring          5.14           22.74          11.50          5.60   
                                 (+21.7 pct)                             
  Net
  Net                2.20           15.91           6.90          3.40   
                                 (+14.0 pct)                             
  EPS             44.72 yen      323.36 yen     140.18 yen    69.08 yen  
  EPS Diluted                    316.19 yen                              
  Ann Div         60.00 yen       60.00 yen      60.00 yen               
  -Q2 Div         30.00 yen       27.00 yen      30.00 yen               
  -Q4 Div         30.00 yen       33.00 yen      30.00 yen               
  
  NOTE - Towa Pharmaceutical Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4553.T